Effects of Acute Exercise and Allopurinol Administration on Soluble Urokinase Plasminogen Activator Receptor (suPAR)

被引:11
|
作者
Sanchis-Gomar, Fabian [1 ]
Bonaguri, Chiara [2 ]
Pareja-Galeano, Helios [1 ]
Carmen Gomez-Cabrera, Mari [1 ]
Candel, Jorge [3 ]
Vina, Jose [1 ]
Lippi, Giuseppe [2 ]
机构
[1] Univ Valencia, Fdn Invest Hosp Clin Univ, Fac Med, Dept Physiol,INCLIVA, Valencia 46010, Spain
[2] Univ Parma, Azienda Osped, UO Diagnost Ematochim, Dipartimento Patol & Med Lab, I-43100 Parma, Italy
[3] Valencia CF Med Serv, Valencia, Spain
关键词
physical exercise; soluble urokinase plasminogen activator receptor; suPAR; allopurinol; EXHAUSTIVE PHYSICAL-EXERCISE; MORTALITY; TOUR;
D O I
10.7754/Clin.Lab.2012.120728
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Background: Although physical exercise acutely increases the most widely used inflammatory biomarkers, there is no information on its effect on soluble urokinase plasminogen activating receptor (suPAR), a circulating biomarker increasingly used for the assessment of systemic inflammation. Methods: suPAR was assessed with the quantitative suPARnostic (R) Standard ELISA Assay (Virogates, Birkerod, Denmark) in 12 professional football players before and after a football match. The athletes were divided into two experimental groups. An oral dose of 300 mg of allopurinol was administered to one group of six participants four hours before a match; the other six participants received placebo. Results: Serum suPAR concentration did not vary significantly after the match in both the placebo and allopurinol group. No significant differences were observed between placebo and allopurinol groups at baseline and after the game. Conclusions: At variance with other consolidated inflammatory biomarkers, suPAR is not influenced by either physical exercise or administration of xanthine oxidase inhibitors.
引用
收藏
页码:207 / 210
页数:4
相关论文
共 50 条
  • [21] Soluble urokinase plasminogen activator receptor (suPAR) for assessment of disease severity in ventilator-associated pneumonia and sepsis
    Savva, Athina
    Raftogiannis, Maria
    Baziaka, Fotini
    Routsi, Christina
    Antonopoulou, Anastasia
    Koutoukas, Pantelis
    Tsaganos, Thomas
    Kotanidou, Anastasia
    Apostolidou, Efterpi
    Giamarellos-Bourboulis, Evangelos J.
    Dimopoulos, George
    JOURNAL OF INFECTION, 2011, 63 (05) : 344 - 350
  • [22] Soluble urokinase plasminogen activator receptor (suPAR) as a prognostic marker in COVID-19 patients: a systematic review
    Lobato-martinez, E.
    Sanchez-martinez, R.
    Balsa, E. de-miguel
    Ramos-rincon, J. -m.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2024, 28 (02) : 852 - 860
  • [23] Measurement of soluble urokinase plasminogen activator receptor in serum
    Riisbro, R
    Piironen, T
    Brünner, N
    Larsen, B
    Nielsen, HJ
    Stephens, RW
    Hoyer-Hansen, G
    JOURNAL OF CLINICAL LIGAND ASSAY, 2002, 25 (01): : 53 - 56
  • [24] Increased Soluble Urokinase-Type Plasminogen Activator Receptor (suPAR) Levels in Plasma of Suicide Attempters
    Ventorp, Filip
    Gustafsson, Anna
    Traskman-Bendz, Lil
    Westrin, Asa
    Ljunggren, Lennart
    PLOS ONE, 2015, 10 (10):
  • [25] The Role of Soluble Urokinase Plasminogen Activator Receptor (suPAR) as an Early Indicator of Mortality in Pediatric Septic Shock
    Turan, Caner
    Yurtseven, Ali
    Ozkaya, Pinar Yazici
    Azarsiz, Elif
    Saz, Eylem Ulas
    JOURNAL OF CLINICAL LABORATORY ANALYSIS, 2024, 38 (09)
  • [26] Serum soluble urokinase plasminogen activator receptor (suPAR) in early pregnancy prior to clinical onset of preeclampsia
    Odden, Nancy
    Henriksen, Tore
    Morkrid, Lars
    ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA, 2012, 91 (10) : 1226 - 1232
  • [27] Diagnostic accuracy of soluble urokinase plasminogen activator receptor (suPAR) for prediction of bacteremia in patients with systemic inflammatory response syndrome
    Hoenigl, Martin
    Raggam, Reinhard B.
    Wagner, Jasmin
    Valentin, Thomas
    Leitner, Eva
    Seeber, Katharina
    Zollner-Schwetz, Ines
    Krammer, Werner
    Prueller, Florian
    Grisold, Andrea J.
    Krause, Robert
    CLINICAL BIOCHEMISTRY, 2013, 46 (03) : 225 - 229
  • [28] Soluble Urokinase Plasminogen Activator Receptor (suPAR) Independently Predicts Severity and Length of Hospitalisation in Patients With COVID-19
    Enocsson, Helena
    Idoff, Cornelia
    Gustafsson, Annette
    Govender, Melissa
    Hopkins, Francis
    Larsson, Marie
    Nilsdotter-Augustinsson, Asa
    Sjowall, Johanna
    FRONTIERS IN MEDICINE, 2021, 8
  • [29] Soluble urokinase plasminogen activator receptor as a long-term prognostic biomarker in acute coronary syndromes
    Peiro, Oscar Manuel
    Cediel, German
    Bonet, Gil
    Rojas, Sergio
    Quintern, Veronica
    Carrasquer, Anna
    Gonzalez-Del-Hoyo, Maribel
    Sanz, Esther
    Bardaji, Alfredo
    BIOMARKERS, 2020, 25 (05) : 402 - 409
  • [30] Prediction value of soluble urokinase plasminogen activator receptor (suPAR) in COVID-19 patients-a systematic review and meta-analysis
    Matuszewski, Michal
    Ladny, Jerzy
    Rafique, Zubaid
    Peacock, Frank
    Pruc, Michal
    Gasecka, Aleksandra
    Szwed, Piotr
    Jankowski, Lukasz
    Chmielewski, Jaroslaw
    Panasiuk, Lech
    Szarpak, Lukasz
    ANNALS OF AGRICULTURAL AND ENVIRONMENTAL MEDICINE, 2023, 30 (01) : 142 - 147